Table 2.
IRRs and site specific cancer ASRs in India and South Asians in California, 1993–1997.
| SITE | SOUTH ASIAN MALES | SOUTH ASIAN FEMALES | ||||
| India ASR1 | California ASR2 | IRR3 | India ASR | California ASR | IRR | |
| All Sites | 99 | 199.6 | 2.0 | 104.4 | 195.7 | 1.9 |
| Oral Cavity | 12.8 | 5.1 | 0.4 | 7.5 | 4.6 | 0.6 |
| Esophagus | 7.6 | 2.6 | 0.3 | 1.9 | 2.4 | 1.3 |
| Stomach | 5.7 | 6 | 1.1 | 2.8 | 5.2 | 1.9 |
| Colon and Rectum | 4.7 | 22.8 | 4.9 | 3.2 | 13.4 | 4.2 |
| Liver & Intrahepatic Bile Duct | 2.3 | 5.3 | 2.3 | 1.1 | 3.1 | 2.8 |
| Pancreas | 1.4 | 4.5 | 3.2 | 0.8 | 4.5 | 5.6 |
| Lung and Bronchus | 9 | 13.9 | 1.5 | 2 | 9.9 | 5.0 |
| Prostate | 4.6 | 69.9 | 15.2 | ~ | ~ | ~ |
| Breast | ~ | ~ | ~ | 19.1 | 66.6 | 3.5 |
| Cervix Uteri | ~ | ~ | ~ | 30.7 | 8.4 | 0.3 |
| Corpus Uteri | ~ | ~ | ~ | 1.7 | 10 | 5.9 |
| Ovary | ~ | ~ | ~ | 4.9 | 10.4 | 2.1 |
| Urinary Bladder | 3.2 | 9.4 | 2.9 | ~ | ~ | ~ |
| Kidney and Renal Pelvis | 1.2 | 4.9 | 4.1 | 0.5 | 2.4 | 4.8 |
| Brain & other CNS | 2.6 | 5.4 | 2.1 | 1.6 | 3.6 | 2.3 |
| Thyroid | 1 | 1.5 | 1.5 | 1.9 | 7.6 | 4.0 |
| Non-Hodgkin Lymphoma | 3.2 | 11.2 | 3.5 | 1.7 | 10.3 | 6.1 |
| Myeloma | 1 | 4.6 | 4.6 | 0.6 | 3.1 | 5.2 |
| Leukemia | 3.1 | 9.9 | 3.2 | 1.9 | 6.8 | 3.6 |
1Rates for India obtained from Globocan 2002, rates are an average of 8 regional cancer registries (1993–1997).
2 Age standardised rates (world population), rates are per 100,000 population.
3 Incidence Rate Ratios, ratio of rates in SAs in California vs Indian cancer rates.
IRRs in bold indicate significantly elevated IRRs in California SAs (p < 0.05).
~ indicates cases less than 10 for California SAs, hence rates are not significant enough to report.